<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32286343</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>14</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Suppressed humoral immunity is associated with dengue nonstructural protein NS1-elicited anti-death receptor antibody fractions in mice.</ArticleTitle><Pagination><StartPage>6294</StartPage><MedlinePgn>6294</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6294</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-62958-0</ELocationID><Abstract><AbstractText>Dengue virus (DENV) infections may cause life-threatening dengue hemorrhagic fever (DHF). Suppressed protective immunity was shown in these patients. Although several hypotheses have been formulated, the mechanism of DENV-induced immunosuppression remains unclear. Previously, we found that cross-reactive antibodies against tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor 1 (death receptor 4 [DR4]) were elicited in DHF patients, and that anti-DR4 autoantibody fractions were elicited by nonstructural protein 1 (NS1) immunizations in experimental mice. In this study, we found that anti-DR4 antibodies could suppress B lymphocyte function in vitro and in vivo. Treatment with the anti-DR4 immunoglobulin (Ig) induced caspase-dependent cell death in immortalized B lymphocyte Raji cells in vitro. Anti-DR4 Igs elicited by NS1 and DR4 immunizations markedly suppressed mouse spleen transitional T2 B (IgM<sup>+</sup>IgD<sup>+</sup>), bone marrow pre-pro-B (B220<sup>+</sup>CD43<sup>+</sup>), pre-B (B220<sup>+</sup>CD43<sup>-</sup>), and mature B cell (B220<sup>+</sup>IgD<sup>+</sup>) subsets in mice. Furthermore, functional analysis revealed that the pre-elicitation of anti-NS1 and anti-DR4 Ig titers suppressed subsequently neutralizing antibody production by immunization with DENV envelop protein. Our data suggest that the elicitation of anti-DR4 titers through DENV NS1 immunization plays a suppressive role in humoral immunity in mice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Tsai</LastName><ForeName>Chung-Lin</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sun</LastName><ForeName>Der-Shan</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Su</LastName><ForeName>Mei-Tzu</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lien</LastName><ForeName>Te-Sheng</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Hsu</ForeName><Initials>YH</Initials><Identifier Source="ORCID">0000-0002-8667-4844</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center of Tropical Medicine and Infectious diseases, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, HsinChu, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chun-Yu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center of Tropical Medicine and Infectious diseases, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chung-Hao</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center of Tropical Medicine and Infectious diseases, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Chwan-Chuen</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chen-Ru</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tai-Hung</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Yu-Hsiang</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Division of Rheumatology/Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Chun-Chi</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Division of Rheumatology/Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Hsin-Hou</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien, Taiwan. hhchang@mail.tcu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C079340">NS1 protein, Dengue virus type 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053220">Receptors, TNF-Related Apoptosis-Inducing Ligand</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056724" MajorTopicYN="Y">Immunity, Humoral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053220" MajorTopicYN="N">Receptors, TNF-Related Apoptosis-Inducing Ligand</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019595" MajorTopicYN="N">Severe Dengue</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32286343</ArticleId><ArticleId IdType="pmc">PMC7156414</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-62958-0</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-62958-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gubler DJ. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 1998;11:480&#x2013;496. doi: 10.1128/CMR.11.3.480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.11.3.480</ArticleId><ArticleId IdType="pmc">PMC88892</ArticleId><ArticleId IdType="pubmed">9665979</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman MG, et al. Dengue: a continuing global threat. Nat. reviews. Microbiology. 2010;8:S7&#x2013;16. doi: 10.1038/nrmicro2460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2460</ArticleId><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S, et al. The global distribution and burden of dengue. Nature. 2013;496:504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomashek, K. M. &amp; Margolis, H. S. In Travelers' Health (ed CDC) Ch. 3 Infectious Diseases Related To Travel, (U.S. Centers for Disease Control and Prevention (CDC), 2013).</Citation></Reference><Reference><Citation>Guzman, M. G. &amp; Harris, E. Dengue. Lancet, 10.1016/S0140-6736(14)60572-9 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25230594</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect. Dis. 2010;10:712&#x2013;722. doi: 10.1016/S1473-3099(10)70166-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70166-3</ArticleId><ArticleId IdType="pmc">PMC3057165</ArticleId><ArticleId IdType="pubmed">20883967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubol S, Halstead SB. How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin. Vaccine Immunol. 2010;17:1829&#x2013;1835. doi: 10.1128/CVI.00316-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00316-10</ArticleId><ArticleId IdType="pmc">PMC3008185</ArticleId><ArticleId IdType="pubmed">20876821</ArticleId></ArticleIdList></Reference><Reference><Citation>Malavige GN, et al. Suppression of virus specific immune responses by IL-10 in acute dengue infection. PLoS neglected tropical Dis. 2013;7:e2409. doi: 10.1371/journal.pntd.0002409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002409</ArticleId><ArticleId IdType="pmc">PMC3764236</ArticleId><ArticleId IdType="pubmed">24040431</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239:476&#x2013;481. doi: 10.1126/science.239.4839.476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.239.4839.476</ArticleId><ArticleId IdType="pubmed">3277268</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Dengue. Lancet. 2007;370:1644&#x2013;1652. doi: 10.1016/S0140-6736(07)61687-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61687-0</ArticleId><ArticleId IdType="pubmed">17993365</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehead SS, Blaney JE, Durbin AP, Murphy BR. Prospects for a dengue virus vaccine. Nat. reviews. Microbiology. 2007;5:518&#x2013;528. doi: 10.1038/nrmicro1690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1690</ArticleId><ArticleId IdType="pubmed">17558424</ArticleId></ArticleIdList></Reference><Reference><Citation>Flipse J, Wilschut J, Smit JM. Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans. Traffic. 2013;14:25&#x2013;35. doi: 10.1111/tra.12012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12012</ArticleId><ArticleId IdType="pubmed">22998156</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, Rojanasuphot S, Sangkawibha N. Original antigenic sin in dengue. Am. J. Trop. Med. Hyg. 1983;32:154&#x2013;156. doi: 10.4269/ajtmh.1983.32.154.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1983.32.154</ArticleId><ArticleId IdType="pubmed">6824120</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 2011;11:532&#x2013;543. doi: 10.1038/nri3014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3014</ArticleId><ArticleId IdType="pubmed">21760609</ArticleId></ArticleIdList></Reference><Reference><Citation>Oishi K, et al. Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections. J. Med. Virol. 2003;71:259&#x2013;264. doi: 10.1002/jmv.10478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10478</ArticleId><ArticleId IdType="pubmed">12938201</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito M, et al. Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin. Exp. Immunol. 2004;138:299&#x2013;303. doi: 10.1111/j.1365-2249.2004.02626.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2004.02626.x</ArticleId><ArticleId IdType="pmc">PMC1809201</ArticleId><ArticleId IdType="pubmed">15498040</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda S, et al. Increased phagocytosis of platelets from patients with secondary dengue virus infection by human macrophages. Am. J. Trop. Med. Hyg. 2009;80:841&#x2013;845. doi: 10.4269/ajtmh.2009.80.841.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2009.80.841</ArticleId><ArticleId IdType="pubmed">19407135</ArticleId></ArticleIdList></Reference><Reference><Citation>Falconar AK. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch. Virol. 1997;142:897&#x2013;916. doi: 10.1007/s007050050127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s007050050127</ArticleId><ArticleId IdType="pubmed">9191856</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, et al. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J. Immunol. 2002;169:657&#x2013;664. doi: 10.4049/jimmunol.169.2.657.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.169.2.657</ArticleId><ArticleId IdType="pubmed">12097367</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YS, et al. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp. Biol. Med. 2011;236:515&#x2013;523. doi: 10.1258/ebm.2011.010339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/ebm.2011.010339</ArticleId><ArticleId IdType="pubmed">21502191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, et al. Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model. Lab. Invest. 2008;88:1079&#x2013;1089. doi: 10.1038/labinvest.2008.70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2008.70</ArticleId><ArticleId IdType="pubmed">18679379</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien TS, et al. Dengue virus and antiplatelet autoantibodies synergistically induce haemorrhage through Nlrp3-inflammasome and FcgammaRIII. Thrombosis Haemost. 2015;113:1060&#x2013;1070. doi: 10.1160/TH14-07-0637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH14-07-0637</ArticleId><ArticleId IdType="pubmed">25740324</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun DS, et al. Endothelial Cell Sensitization by Death Receptor Fractions of an Anti-Dengue Nonstructural Protein 1 Antibody Induced Plasma Leakage, Coagulopathy, and Mortality in Mice. J. Immunol. 2015;195:2743&#x2013;2753. doi: 10.4049/jimmunol.1500136.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500136</ArticleId><ArticleId IdType="pubmed">26259584</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun DS, et al. Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J. thrombosis haemostasis: JTH. 2007;5:2291&#x2013;2299. doi: 10.1111/j.1538-7836.2007.02754.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02754.x</ArticleId><ArticleId IdType="pubmed">17958746</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang YC, Wang SY, Lin YS, Chen HR, Yeh TM. Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection. J. Biomed. Sci. 2013;20:42. doi: 10.1186/1423-0127-20-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-42</ArticleId><ArticleId IdType="pmc">PMC3704815</ArticleId><ArticleId IdType="pubmed">23806052</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang YC, Lin J, Lin YS, Wang S, Yeh TM. Dengue Virus Nonstructural Protein 1-Induced Antibodies Cross-React with Human Plasminogen and Enhance Its Activation. J. Immunol. 2016;196:1218&#x2013;1226. doi: 10.4049/jimmunol.1500057.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500057</ArticleId><ArticleId IdType="pubmed">26712948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay F, Schneider P. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor. Rev. 2008;19:263&#x2013;276. doi: 10.1016/j.cytogfr.2008.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2008.04.006</ArticleId><ArticleId IdType="pubmed">18514565</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay F, Schneider P. Cracking the BAFF code. Nat. Rev. Immunol. 2009;9:491&#x2013;502. doi: 10.1038/nri2572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2572</ArticleId><ArticleId IdType="pubmed">19521398</ArticleId></ArticleIdList></Reference><Reference><Citation>Goenka R, Scholz JL, Sindhava VJ, Cancro MP. New roles for the BLyS/BAFF family in antigen-experienced B cell niches. Cytokine Growth Factor. Rev. 2014;25:107&#x2013;113. doi: 10.1016/j.cytogfr.2014.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2014.01.001</ArticleId><ArticleId IdType="pmc">PMC3999179</ArticleId><ArticleId IdType="pubmed">24507939</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HH, et al. Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen. J. Infect. Dis. 2002;186:743&#x2013;751. doi: 10.1086/342600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/342600</ArticleId><ArticleId IdType="pubmed">12198607</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin GL, et al. Suppressive effect of dengue virus envelope protein domain III on megakaryopoiesis. Virulence. 2017;8:1719&#x2013;1731. doi: 10.1080/21505594.2017.1343769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2017.1343769</ArticleId><ArticleId IdType="pmc">PMC5810469</ArticleId><ArticleId IdType="pubmed">28622093</ArticleId></ArticleIdList></Reference><Reference><Citation>Opferman JT, et al. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature. 2003;426:671&#x2013;676. doi: 10.1038/nature02067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02067</ArticleId><ArticleId IdType="pubmed">14668867</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava B, Quinn WJ, III., Hazard K, Erikson J, Allman D. Characterization of marginal zone B cell precursors. J. Exp. Med. 2005;202:1225&#x2013;1234. doi: 10.1084/jem.20051038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20051038</ArticleId><ArticleId IdType="pmc">PMC2213231</ArticleId><ArticleId IdType="pubmed">16260487</ArticleId></ArticleIdList></Reference><Reference><Citation>Loder F, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 1999;190:75&#x2013;89. doi: 10.1084/jem.190.1.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.190.1.75</ArticleId><ArticleId IdType="pmc">PMC2195560</ArticleId><ArticleId IdType="pubmed">10429672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini-Siegel J, et al. TRAIL/Apo-2 ligand induces primary plasma cell apoptosis. J. Immunol. 2002;169:5505&#x2013;5513. doi: 10.4049/jimmunol.169.10.5505.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.169.10.5505</ArticleId><ArticleId IdType="pubmed">12421926</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro-Cacais AO, Levitskaya J, Levitsky V. B cell receptor triggering sensitizes human B cells to TRAIL-induced apoptosis. J. Leukoc. Biol. 2010;88:937&#x2013;945. doi: 10.1189/jlb.0510246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0510246</ArticleId><ArticleId IdType="pubmed">20709941</ArticleId></ArticleIdList></Reference><Reference><Citation>Uckun FM, et al. Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia. J. Clin. Invest. 2015;125:1006&#x2013;1018. doi: 10.1172/JCI76610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI76610</ArticleId><ArticleId IdType="pmc">PMC4362237</ArticleId><ArticleId IdType="pubmed">25621496</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossen C, Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 2006;18:263&#x2013;275. doi: 10.1016/j.smim.2006.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2006.04.006</ArticleId><ArticleId IdType="pubmed">16914324</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng LG, et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J. Immunol. 2004;173:807&#x2013;817. doi: 10.4049/jimmunol.173.2.807.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.173.2.807</ArticleId><ArticleId IdType="pubmed">15240667</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogue CW, Zhang PX, McGrath J, Jacobs HC, Fuleihan RL. Impaired B cell development and function in mice with a targeted disruption of the homeobox gene Hex. Proc. Natl Acad. Sci. U S Am. 2003;100:556&#x2013;561. doi: 10.1073/pnas.0236979100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0236979100</ArticleId><ArticleId IdType="pmc">PMC141034</ArticleId><ArticleId IdType="pubmed">12522149</ArticleId></ArticleIdList></Reference><Reference><Citation>Cariappa A, Chase C, Liu H, Russell P, Pillai S. Naive recirculating B cells mature simultaneously in the spleen and bone marrow. Blood. 2007;109:2339&#x2013;2345. doi: 10.1182/blood-2006-05-021089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2006-05-021089</ArticleId><ArticleId IdType="pubmed">17119110</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichlin A, et al. B cell development is arrested at the immature B cell stage in mice carrying a mutation in the cytoplasmic domain of immunoglobulin beta. J. Exp. Med. 2001;193:13&#x2013;23. doi: 10.1084/jem.193.1.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.193.1.13</ArticleId><ArticleId IdType="pmc">PMC2195879</ArticleId><ArticleId IdType="pubmed">11136817</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour A, et al. Osteoclast activity modulates B-cell development in the bone marrow. Cell Res. 2011;21:1102&#x2013;1115. doi: 10.1038/cr.2011.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2011.21</ArticleId><ArticleId IdType="pmc">PMC3193501</ArticleId><ArticleId IdType="pubmed">21321604</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung JJ, et al. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J. Virol. 2004;78:378&#x2013;388. doi: 10.1128/JVI.78.1.378-388.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.1.378-388.2004</ArticleId><ArticleId IdType="pmc">PMC303388</ArticleId><ArticleId IdType="pubmed">14671119</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit JM, Moesker B, Rodenhuis-Zybert I, Wilschut J. Flavivirus cell entry and membrane fusion. Viruses. 2011;3:160&#x2013;171. doi: 10.3390/v3020160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3020160</ArticleId><ArticleId IdType="pmc">PMC3206597</ArticleId><ArticleId IdType="pubmed">22049308</ArticleId></ArticleIdList></Reference><Reference><Citation>Watterson D, Kobe B, Young PR. Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding. J. Gen. Virol. 2012;93:72&#x2013;82. doi: 10.1099/vir.0.037317-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.037317-0</ArticleId><ArticleId IdType="pubmed">21957126</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman MG, Hermida L, Bernardo L, Ramirez R, Guillen G. Domain III of the envelope protein as a dengue vaccine target. Expert. Rev. Vaccines. 2010;9:137&#x2013;147. doi: 10.1586/erv.09.139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erv.09.139</ArticleId><ArticleId IdType="pubmed">20109025</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltramello M, et al. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe. 2010;8:271&#x2013;283. doi: 10.1016/j.chom.2010.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.08.007</ArticleId><ArticleId IdType="pmc">PMC3884547</ArticleId><ArticleId IdType="pubmed">20833378</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, O'Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 1977;146:201&#x2013;217. doi: 10.1084/jem.146.1.201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.146.1.201</ArticleId><ArticleId IdType="pmc">PMC2180729</ArticleId><ArticleId IdType="pubmed">406347</ArticleId></ArticleIdList></Reference><Reference><Citation>Teerasut C, et al. The serotype-independent but concentration-dependent enhancing antibodies among Thai dengue patients. Southeast. Asian J. Trop. Med. Public. Health. 2012;43:624&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">23077841</ArticleId></ArticleIdList></Reference><Reference><Citation>Perng GC, Lei HY, Lin YS, Chokephaibulkit K. Dengue Vaccines: Challenge and Confrontation. World. J. Vaccines. 2011;1:109&#x2013;130.</Citation></Reference><Reference><Citation>Sangkawibha N, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 1984;120:653&#x2013;669. doi: 10.1093/oxfordjournals.aje.a113932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a113932</ArticleId><ArticleId IdType="pubmed">6496446</ArticleId></ArticleIdList></Reference><Reference><Citation>Thai KT, et al. Seroprevalence of dengue antibodies, annual incidence and risk factors among children in southern Vietnam. Trop. Med. Int. Health. 2005;10:379&#x2013;386. doi: 10.1111/j.1365-3156.2005.01388.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3156.2005.01388.x</ArticleId><ArticleId IdType="pubmed">15807802</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods. 2004;286:111&#x2013;122. doi: 10.1016/j.jim.2003.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2003.12.015</ArticleId><ArticleId IdType="pubmed">15087226</ArticleId></ArticleIdList></Reference><Reference><Citation>Do RK, Chen-Kiang S. Mechanism of BLyS action in B cell immunity. Cytokine Growth Factor. Rev. 2002;13:19&#x2013;25. doi: 10.1016/S1359-6101(01)00025-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1359-6101(01)00025-9</ArticleId><ArticleId IdType="pubmed">11750877</ArticleId></ArticleIdList></Reference><Reference><Citation>Pers JO, et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann. N. Y. Acad. Sci. 2005;1050:34&#x2013;39. doi: 10.1196/annals.1313.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1313.004</ArticleId><ArticleId IdType="pubmed">16014518</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs HM, et al. Cutting Edge: BAFF Promotes Autoantibody Production via TACI-Dependent Activation of Transitional B Cells. J. Immunol. 2016;196:3525&#x2013;3531. doi: 10.4049/jimmunol.1600017.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600017</ArticleId><ArticleId IdType="pmc">PMC4868625</ArticleId><ArticleId IdType="pubmed">27022196</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldschmidt TJ, Noelle RJ. Immunology. Long live the mature B cell&#x2013;a baffling mystery resolved. Science. 2001;293:2012&#x2013;2013. doi: 10.1126/science.1065591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1065591</ArticleId><ArticleId IdType="pubmed">11557866</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Li J, Zhang YM, Zhang XM, Tao J. Effect of TACI signaling on humoral immunity and autoimmune diseases. J. Immunol. Res. 2015;2015:247426. doi: 10.1155/2015/247426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/247426</ArticleId><ArticleId IdType="pmc">PMC4381970</ArticleId><ArticleId IdType="pubmed">25866827</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan M, et al. Activation and accumulation of B cells in TACI-deficient mice. Nat. immunology. 2001;2:638&#x2013;643. doi: 10.1038/89790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/89790</ArticleId><ArticleId IdType="pubmed">11429549</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, et al. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat. immunology. 2000;1:252&#x2013;256. doi: 10.1038/79802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/79802</ArticleId><ArticleId IdType="pubmed">10973284</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, et al. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat. immunology. 2001;2:632&#x2013;637. doi: 10.1038/89782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/89782</ArticleId><ArticleId IdType="pubmed">11429548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross JA, et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity. 2001;15:289&#x2013;302. doi: 10.1016/S1074-7613(01)00183-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(01)00183-2</ArticleId><ArticleId IdType="pubmed">11520463</ArticleId></ArticleIdList></Reference><Reference><Citation>Figgett WA, et al. The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death. Immunity. 2013;39:573&#x2013;583. doi: 10.1016/j.immuni.2013.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.05.019</ArticleId><ArticleId IdType="pubmed">24012421</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnberg N, Klein-Szanto AJ, El-Deiry WS. TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis. J. Clin. Invest. 2008;118:111&#x2013;123. doi: 10.1172/JCI29900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI29900</ArticleId><ArticleId IdType="pmc">PMC2129232</ArticleId><ArticleId IdType="pubmed">18079962</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, et al. TRAIL receptor deficiency sensitizes mice to dextran sodium sulphate-induced colitis and colitis-associated carcinogenesis. Immunology. 2014;141:211&#x2013;221. doi: 10.1111/imm.12181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12181</ArticleId><ArticleId IdType="pmc">PMC3904242</ArticleId><ArticleId IdType="pubmed">24117005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chen YH. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL&#x2212;/&#x2212; mice. Nat. immunology. 2003;4:255&#x2013;260. doi: 10.1038/ni894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni894</ArticleId><ArticleId IdType="pubmed">12577054</ArticleId></ArticleIdList></Reference><Reference><Citation>Falschlehner C, Schaefer U, Walczak H. Following TRAIL's path in the immune system. Immunology. 2009;127:145&#x2013;154. doi: 10.1111/j.1365-2567.2009.03058.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2009.03058.x</ArticleId><ArticleId IdType="pmc">PMC2691779</ArticleId><ArticleId IdType="pubmed">19476510</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Lostao L, Marzo I, Anel A, Naval J. Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer. Biochem. Pharmacol. 2012;83:1475&#x2013;1483. doi: 10.1016/j.bcp.2011.12.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2011.12.036</ArticleId><ArticleId IdType="pubmed">22230480</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgakis GV, et al. Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death. Br. J. Haematol. 2005;130:501&#x2013;510. doi: 10.1111/j.1365-2141.2005.05656.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2005.05656.x</ArticleId><ArticleId IdType="pubmed">16098063</ArticleId></ArticleIdList></Reference><Reference><Citation>Pukac L, et al. HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo. Br. J. Cancer. 2005;92:1430&#x2013;1441. doi: 10.1038/sj.bjc.6602487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjc.6602487</ArticleId><ArticleId IdType="pmc">PMC2361994</ArticleId><ArticleId IdType="pubmed">15846298</ArticleId></ArticleIdList></Reference><Reference><Citation>Motoki K, et al. Enhanced apoptosis and tumor regression induced by a direct agonist antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2. Clin. Cancer Res. 2005;11:3126&#x2013;3135. doi: 10.1158/1078-0432.CCR-04-1867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-04-1867</ArticleId><ArticleId IdType="pubmed">15837769</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlow, E. &amp; Lane, D. Antibodies: A Laboratory Manual. (Cold Spring Harbor Laboratory, 1988).</Citation></Reference><Reference><Citation>Chang HH, et al. Cell adhesion as a novel approach to determining the cellular binding motif on the severe acute respiratory syndrome coronavirus spike protein. J. Virol. Methods. 2014;201:1&#x2013;6. doi: 10.1016/j.jviromet.2014.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2014.01.022</ArticleId><ArticleId IdType="pmc">PMC7113645</ArticleId><ArticleId IdType="pubmed">24530430</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YY, Hu CT, Sun DS, Lien TS, Chang HH. Thioacetamide-induced liver damage and thrombocytopenia is associated with induction of antiplatelet autoantibody in mice. Sci. Rep. 2019;9:17497. doi: 10.1038/s41598-019-53977-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-53977-7</ArticleId><ArticleId IdType="pmc">PMC6877565</ArticleId><ArticleId IdType="pubmed">31767905</ArticleId></ArticleIdList></Reference><Reference><Citation>Perevedentseva E, Krivokharchenko A, Karmenyan AV, Chang HH, Cheng CL. Raman spectroscopy on live mouse early embryo while it continues to develop into blastocyst in vitro. Sci. Rep. 2019;9:6636. doi: 10.1038/s41598-019-42958-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42958-5</ArticleId><ArticleId IdType="pmc">PMC6488652</ArticleId><ArticleId IdType="pubmed">31036868</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan H, et al. TRPM8 and RAAS-mediated hypertension is critical for cold-induced immunosuppression in mice. Oncotarget. 2018;9:12781&#x2013;12795. doi: 10.18632/oncotarget.24356.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.24356</ArticleId><ArticleId IdType="pmc">PMC5849173</ArticleId><ArticleId IdType="pubmed">29560109</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Ch. 2: Clinical diagnosis, 12&#x2013;23 (World Health Organization, 1997, Chapter 2).</Citation></Reference><Reference><Citation>WHO. Dengue: guidelines for diagnosis, treatment, prevention and control. New edn, 11-28 (World Health Organization, 2009).</Citation></Reference><Reference><Citation>Phelan K, May KM. Mammalian Cell Tissue Culture Techniques. Curr. Protoc. Mol. Biol. 2017;117:A 3F 1&#x2013;A 3F 23. doi: 10.1002/cpmb.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpmb.31</ArticleId><ArticleId IdType="pubmed">28060407</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng PH, et al. Identification of two novel small compounds that inhibit liver cancer formation in zebrafish and analysis of their conjugation to nanodiamonds to further reduce toxicity. Adv. Therapeutics. 2019;2(1900105):1900101&#x2013;1900114.</Citation></Reference><Reference><Citation>Wu MS, et al. Nanodiamonds protect skin from ultraviolet B-induced damage in mice. J. nanobiotechnology. 2015;13:35. doi: 10.1186/s12951-015-0094-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12951-015-0094-4</ArticleId><ArticleId IdType="pmc">PMC4432518</ArticleId><ArticleId IdType="pubmed">25947194</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun DS, et al. Acquired coagulant factor VIII deficiency induced by Bacillus anthracis lethal toxin in mice. Virulence. 2015;6:466&#x2013;475. doi: 10.1080/21505594.2015.1031454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2015.1031454</ArticleId><ArticleId IdType="pmc">PMC4601479</ArticleId><ArticleId IdType="pubmed">25906166</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu MS, et al. Nanodiamonds protect skin from ultraviolet B-induced damage in mice. J. Nanobiotechnology. 2015;13:35. doi: 10.1186/s12951-015-0094-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12951-015-0094-4</ArticleId><ArticleId IdType="pmc">PMC4432518</ArticleId><ArticleId IdType="pubmed">25947194</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HH, Kau JH, Lo SJ, Sun DS. Cell-adhesion and morphological changes are not sufficient to support anchorage-dependent cell growth via non-integrin-mediated attachment. Cell Biol. Int. 2003;27:123&#x2013;133. doi: 10.1016/S1065-6995(02)00295-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1065-6995(02)00295-0</ArticleId><ArticleId IdType="pubmed">12662969</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HH, et al. Erythrocytic mobilization enhanced by the granulocyte colony-stimulating factor is associated with reduced anthrax-lethal-toxin-induced mortality in mice. PLoS one. 2014;9:e111149. doi: 10.1371/journal.pone.0111149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0111149</ArticleId><ArticleId IdType="pmc">PMC4226491</ArticleId><ArticleId IdType="pubmed">25384016</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HH, et al. Erythropoiesis suppression is associated with anthrax lethal toxin-mediated pathogenic progression. PLoS one. 2013;8:e71718. doi: 10.1371/journal.pone.0071718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0071718</ArticleId><ArticleId IdType="pmc">PMC3747219</ArticleId><ArticleId IdType="pubmed">23977125</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen PK, et al. Suppressive effects of anthrax lethal toxin on megakaryopoiesis. PLoS one. 2013;8:e59512. doi: 10.1371/journal.pone.0059512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0059512</ArticleId><ArticleId IdType="pmc">PMC3605335</ArticleId><ArticleId IdType="pubmed">23555687</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HS, Sun DS, Lien TS, Chang HH. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice. Blood. 2010;116:5002&#x2013;5009. doi: 10.1182/blood-2010-03-275123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-03-275123</ArticleId><ArticleId IdType="pubmed">20699442</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>